Overview / Abstract: |
The U.S. opioid crisis has fueled injection drug use (IDU), causing a dramatic increase in hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections, with IDU accounting for one in 10 new HIV infections. While effective treatment options for HIV and HCV are available, barriers within OUD populations, such as high-risk behaviors, make testing and treatment difficult, but routine and repeated HIV and HCV testing should be offered to patients with OUD, with point-of-care testing being key to improving care and reducing forward transmission of HIV and hepatitis C. Part One of this CME Outfitters Briefcase, a case-based faculty interview, examines a real-world case highlighting strategies for testing at-risk patients for HIV and HCV, including OUD populations. Further, faculty will discuss how to interpret lab results and the appropriate steps to take for this patient population. At the end of this CE activity, participants should be able to: The following learning objectives pertain only to those requesting CNE or |
Expiration |
Dec 31, 2020 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Psychology CE |
Format |
Webinar / Webcast / Video |
Credits / Hours |
0.5 AMA PRA Category 1 Credit(s) |
Accreditation |
ACCME, ACPE, ABIM/MOC, AANP, AAPA |
Presenters / Authors / Faculty |
Carlos Malvestutto, MD, MPH Jaimie P. Meyer, MD, MS, FACP David Alain Wohl, MD |
Activity Specialities / Related Topics |
Diversion, Education / Teaching, Immunology / Immunosuppression, Pharmacology, Primary Care, Psychiatry / Mental Health, Public Health / Community Health, Substance Abuse / Dependence |
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Gilead Sciences, Inc. |
Keywords / Search Terms |
CME Outfitters HIV testing, HCV testing, HIV/AIDS, HCV, Infectious Diseases, opioid crisis, injection drug use, IDU Free CE CME |